Business Standard

Govt tightens export ban on anti-malarial drug amid coronavirus outbreak

On March 25, the government banned export of anti-malarial drug hydroxychloroquine with immediate effect to ensure sufficient availability of the medicine in the domestic market.

medicine, pharma
Premium

The drug is also not allowed to be shipped by export-oriented units (EOUs) or under any export promotion scheme.

Press Trust of India New Delhi

 
The government has tightened the export ban norms on anti-malarial drug hydroxychloroquine by including special economic zones (SEZs) under its prohibition ambit to ensure there is no shortfall during Covid-19 crisis.

The drug is also not allowed to be shipped by export-oriented units (EOUs) or under any export promotion scheme.

"The export of hydroxychloroquine and formulations made from hydroxychloroquine...is no longer allowed from SEZs/EOUs or against Advance Authorisation or against full advance payment...The export shall remain prohibited without any exception," the directorate general of foreign trade (DGFT) has said in a notification.

Under the advance authorisation (AA) scheme, firms are allowed to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in